Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramChief Financial OfficerCIK 0001815308
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 5 | Piekos BrianChief Financial Officer |  KALVKalVista Pharmaceuticals, Inc.Disposition to issuer | D | — 93.8K sh | Jun 11, 2026 traded Jun 11, 2026 | |
Piekos BrianChief Financial Officer |
| KALVKalVista Pharmaceuticals, Inc. Disposition to issuer |
| D |
| — 55.0K sh |
| Jun 11, 2026 traded Jun 11, 2026 |
| 5 | Piekos BrianChief Financial Officer | KALVKalVista Pharmaceuticals, Inc. Disposition to issuer | D | — 100.0K sh | Jun 11, 2026 traded Jun 11, 2026 |
| 5 | Piekos BrianChief Financial Officer | KALVKalVista Pharmaceuticals, Inc. Disposition to issuer | D | — 21.7K sh | Jun 11, 2026 traded Jun 11, 2026 |
| 9 | Piekos BrianChief Financial Officer | KALVKalVista Pharmaceuticals, Inc. Option exercise | M | — 6,250 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 13 | Piekos BrianChief Financial Officer | KALVKalVista Pharmaceuticals, Inc. Option exercise | M | — 6,250 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 31 | Piekos BrianChief Financial Officer | KALVKalVista Pharmaceuticals, Inc. Open-market sale | SELL | $38K 1,862 sh | Apr 20, 2026 traded Apr 17, 2026 |
| 11 | Piekos BrianChief Financial Officer | KALVKalVista Pharmaceuticals, Inc. Grant or award | A | — 100.0K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 15 | Piekos BrianChief Financial Officer | KALVKalVista Pharmaceuticals, Inc. Option exercise | M | — 15.0K sh | Nov 26, 2025 traded Nov 21, 2025 |
| 23 | Piekos BrianChief Financial Officer | KALVKalVista Pharmaceuticals, Inc. Option exercise | M | — 15.0K sh | Nov 26, 2025 traded Nov 21, 2025 |
| 42 | Piekos BrianChief Financial Officer | KALVKalVista Pharmaceuticals, Inc. Open-market sale | SELL | $60K 4,471 sh | Nov 26, 2025 traded Nov 24, 2025 |